Logotype for Soligenix Inc

Soligenix (SNGX) investor relations material

Soligenix Q3 2025 earnings summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for Soligenix Inc
Q3 2025 earnings summary7 Nov, 2025

Executive summary

  • Focused on developing and commercializing therapies for rare diseases, with two segments: Specialized BioTherapeutics and Public Health Solutions.

  • Key pipeline programs include HyBryte™ for CTCL, SGX302 for psoriasis, SGX942/SGX945 for inflammatory diseases, and multiple vaccine candidates.

  • Ongoing clinical trials and regulatory engagement, including a second Phase 3 trial for HyBryte™ and expansion into new indications.

Financial highlights

  • Net loss of $2.53 million for Q3 2025, up from $1.72 million in Q3 2024; net loss of $8.18 million for the nine months ended September 30, 2025, compared to $5.28 million in the prior year period.

  • Research and development expenses rose to $1.58 million for Q3 2025 (from $0.97 million) and $5.20 million for the nine months (from $2.56 million), mainly due to clinical trial costs.

  • General and administrative expenses were $996,604 for Q3 2025 and $3.17 million for the nine months, both slightly higher year-over-year.

  • Cash and cash equivalents were $10.53 million as of September 30, 2025, up from $7.82 million at year-end 2024, primarily due to a $7.5 million public offering.

  • Working capital increased to $7.46 million from $3.98 million at year-end 2024.

Outlook and guidance

  • Sufficient resources to support operations and development activities for at least the next twelve months.

  • Plans to submit additional grant applications, pursue partnerships, and explore further equity, royalty, or debt financing.

  • Research and development expenditures expected to be approximately $3.8 million over the next 12 months, with no anticipated contract or grant reimbursements.

Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.

Next Soligenix earnings date

Logotype for Soligenix Inc
Q4 202518 Mar, 2026
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next Soligenix earnings date

Logotype for Soligenix Inc
Q4 202518 Mar, 2026

The essential earnings season companion

The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

Soligenix Inc is a U.S.-based biopharmaceutical company focused on developing and commercializing treatments for rare diseases and biodefense indications. The company works on therapies for inflammatory conditions, oncology, and infectious diseases, with both proprietary drug candidates and government-supported programs. The company is headquartered in Princeton, New Jersey, and its shares are listed on the NASDAQ.

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage